Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer’s disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea

BACKGROUND: Vortioxetine has demonstrated procognitive effects in patients with major depressive disorder (MDD). We assessed the effectiveness and safety of vortioxetine in a cohort of patients with MDD and comorbid Alzheimer’s disease participating in a large post-marketing surveillance study in So...

Descripción completa

Detalles Bibliográficos
Autores principales: Cumbo, Eduardo, Adair, Michael, Åstrom, Daniel Oudin, Christensen, Michael Cronquist
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868833/
https://www.ncbi.nlm.nih.gov/pubmed/36698860
http://dx.doi.org/10.3389/fnagi.2022.1037816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868833/
https://www.ncbi.nlm.nih.gov/pubmed/36698860
http://dx.doi.org/10.3389/fnagi.2022.1037816

Ejemplares similares